SM
AVNS icon

Sciencast Management’s Avanos Medical AVNS Stock Holding History

Sciencast Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,138
Closed -$407K – 373
2021
Q2 		$407K Buy
11,138
+5,835
+110% +$241K 0.09% 317
2021
Q1 		$228K Buy
+5,303
New +$249K 0.05% 440

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sciencast Management's AVNS Position: Q3 2021 in Review

Sciencast Management sold out of Avanos Medical (AVNS) in Q3 2021, closing a stake of 11,138 shares — an estimated $407K sold.

Sciencast Management first reported a position in AVNS in Q1 2021 and held it in 2 quarters. The position peaked at $407K in Q2 2021. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2021.

  • Sciencast Management reported no remaining Avanos Medical position as of Q3 2021 after selling out during the quarter.
  • Sciencast Management sold 11,138 Avanos Medical shares in Q3 2021, an estimated $407K.
  • Sciencast Management first reported a position in Avanos Medical in Q1 2021 and held it in 2 quarters.
  • Sciencast Management's Avanos Medical position peaked at $407K in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2021.

Based on Sciencast Management's 13F filing for Q3 2021, filed 21 Oct 2021.